Healthcare Triangle annual r&d spending
2020
2021
2022
2023
2024
2025
Healthcare Triangle R&D Spending Growth & History (HCTI)
Healthcare Triangle's r&d spending was $536,000 for fiscal 2025.
View full Healthcare Triangle company overviewHealthcare Triangle annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $536,000 | $107,000 | +24.94% |
| 2024 | 2024-12-31 | $429,000 | −$370,000 | −46.31% |
| 2023 | 2023-12-31 | $799,000 | −$7.3M | −90.18% |
| 2022 | 2022-12-31 | $8.1M | $2.9M | +54.80% |
| 2021 | 2021-12-31 | $5.3M | $3.5M | +201.59% |
| 2020 | 2020-12-31 | $1.7M | — | — |
Healthcare Triangle quarterly r&d spending
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $51,000 | −$4,000 | −7.27% |
| Q1 2026 | 2026-03-31 | $85,000 | −$59,000 | −40.97% |
| Q4 2025 | 2025-12-31 | $278,000 | — | — |
| Q3 2025 | 2025-09-30 | $59,000 | −$116,000 | −66.29% |
| Q2 2025 | 2025-06-30 | $55,000 | −$152,000 | −73.43% |
| Q1 2025 | 2025-03-31 | $144,000 | $17,000 | +13.39% |
| Q3 2024 | 2024-09-30 | $175,000 | $121,000 | +224.07% |
| Q2 2024 | 2024-06-30 | $207,000 | $105,000 | +102.94% |
| Q1 2024 | 2024-03-31 | $127,000 | −$412,000 | −76.44% |
| Q4 2023 | 2023-12-31 | $104,000 | −$4.9M | −97.90% |
| Q3 2023 | 2023-09-30 | $54,000 | −$1.4M | −96.33% |
| Q2 2023 | 2023-06-30 | $102,000 | −$544,000 | −84.21% |
| Q1 2023 | 2023-03-31 | $539,000 | −$527,000 | −49.44% |
| Q4 2022 | 2022-12-31 | $5.0M | $3.5M | +234.12% |
| Q3 2022 | 2022-09-30 | $1.5M | −$733,000 | −33.26% |
| Q2 2022 | 2022-06-30 | $646,000 | −$167,000 | −20.54% |
| Q1 2022 | 2022-03-31 | $1.1M | $309,000 | +40.82% |
| Q4 2021 | 2021-12-31 | $1.5M | — | — |
| Q3 2021 | 2021-09-30 | $2.2M | $1.7M | +300.61% |
| Q2 2021 | 2021-06-30 | $813,000 | — | — |
| Q1 2021 | 2021-03-31 | $757,000 | — | — |
| Q3 2020 | 2020-09-30 | $550,167 | — | — |
Healthcare Triangle r&d spending trends
Over the last five fiscal years, Healthcare Triangle's r&d spending decreased from $1.7M to $536,000, a change of −$1.2M. The latest reported quarter, Q2 2026, shows $51,000.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Healthcare Triangle source filings ↗